Opioids: an unexplored option for treatment of dyspnea in IPF - Wikidata - wikimedia - TriplyDB

Opioids: an unexplored option for treatment of dyspnea in IPF

Opioids: an unexplored option for treatment of dyspnea in IPF

http://www.wikidata.org/entity/Q26766233

about

Chronic breathlessness in patients with idiopathic pulmonary fibrosis: a major challenge for caregivers.Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group.Optimizing quality of life in patients with idiopathic pulmonary fibrosis.Recent advances in managing idiopathic pulmonary fibrosis.Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.Interstitial lung disease points to consider for clinical trials in systemic sclerosis.Danish respiratory society position paper: palliative care in patients with chronic progressive non-malignant lung diseases

P2860

Q38987215-3CE80E49-F549-43B3-9664-F74F5687045A Q39013034-82476D01-3A8B-4B53-B630-B88C81A5F81B Q39108878-3A3183E7-0AB2-41CF-96A8-AD4DBC6242A1 Q47157713-BB0C0BF5-380C-4977-B3E7-48AE483C5046 Q47791471-8B63B6CE-4AD3-4633-BC35-8D07ED8A74F4 Q49384982-64A6FEAD-A93B-4FA0-97C3-E33A5401B82B Q57814235-DD2E88B6-6010-4B32-ADD3-3FB5FF60B81F

P2860

Opioids: an unexplored option for treatment of dyspnea in IPF

http://www.wikidata.org/entity/Q26766233

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Opioids: an unexplored option for treatment of dyspnea in IPF

@ast

Opioids: an unexplored option for treatment of dyspnea in IPF

@en

Opioids: an unexplored option for treatment of dyspnea in IPF

@nl

type

label

Opioids: an unexplored option for treatment of dyspnea in IPF

@ast

Opioids: an unexplored option for treatment of dyspnea in IPF

@en

Opioids: an unexplored option for treatment of dyspnea in IPF

@nl

prefLabel

Opioids: an unexplored option for treatment of dyspnea in IPF

@ast

Opioids: an unexplored option for treatment of dyspnea in IPF

@en

Opioids: an unexplored option for treatment of dyspnea in IPF

@nl

P1433

Q26766233-C6BDF6AD-795B-4A8B-9473-9280B70D135D

P1476

Q26766233-EA9FEDF9-88FF-40F2-AA5D-FCEBC30A1025

P2093

Q26766233-906624AE-1F9C-4D6B-B593-74EE06E40B27

Q26766233-BB07A4EA-6444-4788-AE13-81826FD7818E

P2860

Q26766233-0114CC12-0293-47FF-9447-AFFFF80B4B0E

Q26766233-10715041-C149-4D35-9C9A-B1213E4728F8

Q26766233-11ED6AA8-EA5F-4F02-AA89-3CD180D2D4D2

Q26766233-12B6B556-025B-413C-B582-5ACFEA186625

Q26766233-17BCE8FE-C56C-48C7-B62C-8BA78388053D

Q26766233-262F56C6-A6EE-4B2A-9A8E-8E0C9073584C

Q26766233-2C7625BD-384F-4958-84FC-F96D13305C75

Q26766233-3FD6FDBF-BFC4-450B-BFC1-EAF93DEB4ADA

Q26766233-44BA795C-A367-41AC-8600-0A5C387CD37F

Q26766233-4503BF6C-78EC-4A38-923A-EA370C7CB399

P304

Q26766233-4F2788CF-88CF-4F8C-93DB-5B4A6E595FE2

P31

Q26766233-F51827BC-4E35-489B-896E-EDCCF1A2E81B

P356

Q26766233-4BF9B000-84CC-43AA-B66A-6322B6E9153A

P407

Q26766233-E5804F39-B943-461C-B76F-D30F6A9084A4

P433

Q26766233-5B580098-A67A-441A-8ED4-A5CE80E0CFD9

P478

Q26766233-DE2FD76B-1B66-4AA8-89C9-7547BB16729F

P50

Q26766233-A6D5FB64-0BB1-43AE-84D6-EBB7572918C3

P577

Q26766233-E4241FC1-ED48-4548-A097-61F5062700D6

P5875

Q26766233-A12189B7-9E2B-48D6-A6A2-F69E565FFEA5

P698

Q26766233-13EDE1BD-68FC-457C-9CA2-6312E611A7F7

P921

Q26766233-430C2E5E-ABE8-4682-9CB3-1E2C84E32B94

P932

Q26766233-DDDF0C35-B26B-4BAC-A726-87FBD70638A3

P356

P1433

European clinical respiratory journal

P1476

Opioids: an unexplored option for treatment of dyspnea in IPF

@en

P2093

Charlotte Kohberg

http://www.w3.org/2001/XMLSchema#string

Elisabeth Bendstrup

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis

An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease.

A systematic review of the use of opioids in the management of dyspnoea.

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.

Dihydrocodeine for breathlessness in "pink puffers".

Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea

Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale.

Peripheral opioid receptors and the cough reflex.

P304

30629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3402/ECRJ.V3.30629

http://www.w3.org/2001/XMLSchema#string

P407

P433

0

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Charlotte U Andersen

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297751855

http://www.w3.org/2001/XMLSchema#string

P698

26969472

http://www.w3.org/2001/XMLSchema#string

P921

P932

4788766

http://www.w3.org/2001/XMLSchema#string